moderna vaccine - Search News

Order byBest matchMost fresh

Moderna Wins FDA Approval

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early s...

· 10h

· 13h · on MSN

FDA approves Moderna's new lower-dose COVID-19 vaccine

· 21h

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

FDA approves new Moderna COVID-19 vaccine

It was the first such approval since FDA tightened COVID vaccine standards and required drugmakers to conduct more studies before approving updated shots for healthy adults under 65.

Axios · 16h

STAT · 17h

FDA approves a next-generation Covid vaccine from Moderna, with restrictions

· 19h

Moderna wins FDA nod for next-gen COVID-19 shot

2don MSN

Trump administration yanks Moderna's bird flu vaccine research funding

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the company’s shot.

U.S. Ends $600M Moderna Bird Flu Vaccine Contract

THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains, raising concern among experts.

2don MSN

US cancels more than $700 million funding for Moderna bird flu vaccine

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced on Wednesday.

3don MSN

HHS cancels $590 million contract with Moderna for bird flu vaccine

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to protect against bird flu amid the agency’s broader efforts to reevaluate therapies that use mRNA technology.